Understand Treatment Limitations

Modern IBD treatments have come a long way, offering many patients significant relief and even remission. However, no treatment works for everyone, and understanding the realistic expectations for each therapy is an important part of managing your condition effectively.

Biologic therapies, small molecules, immunomodulators, and corticosteroids each have different mechanisms, response rates, and timelines. Knowing what to expect — and what questions to ask — helps you make informed decisions alongside your care team.

It's important to understand that clinical trials report response rates — not cure rates. A medication that shows a 40-60% response rate in trials means that a significant portion of patients may not respond. This isn't a failure of the patient; it reflects the complex biology of IBD.

Some treatments take weeks or months to reach full effect. Biologics, for instance, may require several infusions or injections before you notice improvement. During this period, your doctor may use bridge therapies to manage symptoms while waiting for the primary treatment to take hold.

Don't hesitate to ask your doctor direct questions: "What is the expected response rate for this treatment?" "How long before we know if it's working?" "What are our options if this doesn't work?" These are not confrontational questions — they're essential to shared decision-making.

Understanding treatment limitations doesn't mean losing hope. It means approaching your care with clarity and realistic expectations, which ultimately leads to better outcomes and less frustration along the way.